[artículo] 
inEuropean Neuropsychopharmacology > Año 2016 - Vol. 26 - No. 4 (Abril) . - pp. 705-716

Título :	Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression -- The EMC trial
Tipo de documento:	texto impreso
Autores:	André Tadic, Autor ; Daniel Wachtlin, Autor ; Matthias Berger, Autor
Fecha de publicación:	2021
Artículo en la página:	pp. 705-716
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Trastorno depresivo mayor, Antidepresivos, Farmacoterapia, RCT, Mejora temprana, Pautas
Resumen:	Patients with Major Depressive Disorder (MDD) and no improvement after two weeks of antidepressant pharmacotherapy have a high risk of treatment failure. The aim of the study was to determine whether an early medication change (EMC) strategy is superior to a guideline-based treatment in MDD patients without improvement after two weeks of antidepressant pharmacotherapy.
Link:	./index.php?lvl=notice_display&id=26570

[artículo] Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression -- The EMC trial [texto impreso] / André Tadic, Autor ; Daniel Wachtlin, Autor ; Matthias Berger, Autor . - 2021 . - pp. 705-716.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in European Neuropsychopharmacology > Año 2016 - Vol. 26 - No. 4 (Abril) . - pp. 705-716

Palabras clave:	Trastorno depresivo mayor, Antidepresivos, Farmacoterapia, RCT, Mejora temprana, Pautas
Resumen:	Patients with Major Depressive Disorder (MDD) and no improvement after two weeks of antidepressant pharmacotherapy have a high risk of treatment failure. The aim of the study was to determine whether an early medication change (EMC) strategy is superior to a guideline-based treatment in MDD patients without improvement after two weeks of antidepressant pharmacotherapy.
Link:	./index.php?lvl=notice_display&id=26570